Jun 09, 2021 / 07:00PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Welcome, everybody. My name is Matt Sykes, Senior Life Sciences Tools and Diagnostics Analyst at Goldman Sachs. And I have the pleasure of having the NeoGenomics' management team to present to us today.
I just wanted to introduce them real quickly. Doug VanOort, the Executive Chairman; Katheryn McKenzie, the CFO; Doug Brown is the Chief Strategy and Corporate Development Officer; Clive Morris, the CEO of Inivata; and Charlie Eidson, Manager of IR, Strategy and Corporate Development.
Everybody, thank you very much for joining. We're really happy to have you here. And maybe I'll start out and turn it over to you, Doug VanOort, maybe just kind of give us sort of a background on NeoGenomics and maybe some of the recent trends you're seeing and just a bit of -- to kind of set the stage for us a little bit.
Douglas M. VanOort - NeoGenomics Laboratories, Inc. - Executive Chairman
Great. Thank you, Matt. And thanks, everyone, for joining us for this. I'll just
Neogenomics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers